|
Information For:
|
Submit Monographs and RevisionsParticipation in USP's public standards-setting process by the pharmaceutical industry and other stakeholders is vital to the development of authoritative, relevant USP–NF monographs. Interested parties can participate in any of the following ways:
Submit New MonographsUSP encourages you to submit draft monographs for your non-complex and complex drug substances and dosage forms as well as excipients. Your draft monograph will become the starting point for the official public standard. USP staff will involve you in a process of public review and comment to refine and finalize these monographs for publication in the USP–NF. See a priority list of items for which USP requires monographs. Monograph Submission GuidelinesTo review Monograph Submission Guidelines, click here. USP would like you to include the following information in draft monographs that you submit:
Please submit your draft monographs or email your questions on submission to Karen A. Russo, Ph.D., . Additional Requirements for Active Substances
Additional Requirements for Dosage Forms
Download a PDF of the complete monograph submission and revision guidelines. What's New
![]() USP recalled USP 33-NF 28 on Jan. 8, 2010. A reissue product will be available in April 2010.
PF 36(2), March-April 2010: IRAs and Errata (03/01/10) February Revision Bulletins (02/26/10) Protamine Monographs: Notice of Intent to Revise (02/26/10) New Draft Pending Standard for the month of February (02/26/10) PF 36(2), March-April 2010: Highlights (02/22/10) Calculation Tool for the Performance Verification Test (PVT) of Dissolution Assemblies (02/22/10) Performance of Equipment to Test Dissolution of Medications Further Assured (02/09/10) New Official Text (01/29/10) Related Resources |
||||||||||||||||||||||||||||
Copyright © 2010 The United States Pharmacopeial Convention
|
|||||||||||||||||||||||||||||